Leading EDC Provider and Global CRO Continue to Drive Further Adoption of
NEW YORK & DUBLIN, IRELAND, March 6 /CNW/ - Medidata Solutions, a global
provider of electronic clinical data capture (EDC), management and reporting
solutions, and ICON, a global provider of outsourced development services,
today reached a two-year milestone in their partnership.
Since February 2005, the companies have worked together to deliver
Medidata's Rave EDC platform to biopharmaceutical companies around the globe
and to date, ICON and Medidata have been awarded contracts from 19 companies
for 37 clinical trials across Phases I-IV, in a range of therapeutic areas.
ICON, an early adopter of EDC technology, was Medidata's first ASPire to
Win(TM) partner. This program, which is based on a non-exclusive application
service provider (ASP) partnership and business model, has enabled ICON to
meet sponsor demand for Medidata Rave(R). ICON has been able to offer the
platform in-house by building and deploying studies with Rave certified
resources, while the program has also allowed Medidata to implement Rave with
a range of sponsors looking to streamline global clinical trials.
"ICON's proven ability to provide clinical research process and data
management expertise complements Medidata's industry-leading technology and
hosting services, offering sponsors a robust and flexible Rave implementation
model," said Tarek Sherif, CEO of Medidata Solutions. "We value our
partnership with ICON and anticipate further success in 2007."
Tom O'Leary, Global Head of Data Management at ICON, added, "Our
partnership with Medidata has proven extremely beneficial in enabling us to
offer our growing customer base with a user-friendly, flexible solution to
help drive further adoption of EDC for clinical trials worldwide. We look
forward to building on the success of the past two years as we continue to
provide innovative solutions to clients throughout 2007 and beyond."
Through this partnership, ICON and Medidata will continue to work
together on marketing initiatives that demonstrate how EDC technology adoption
can significantly enhance the clinical trials process.
About Medidata Solutions Worldwide
Medidata Solutions helps the world's leading pharmaceutical,
biotechnology, medical device and research organizations maximize the value of
their clinical research investments. Innovative process design, technology and
services streamline clinical trials by providing early visibility to reliable
clinical data - the lifeblood of every research organization. Working with
companies and institutions both large and small, Medidata Solutions helps
clinical researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80 countries.
Medidata Solutions brings significant value to its broad client base with deep
clinical experience and expertise in more than 20 therapeutic areas, projects
in Phase I, II, III, IV, registries and surveillance, and studies with
thousands of investigators and tens-of-thousands of subjects. For more
information, please visit www.mdsol.com.
ICON is a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries. We specialize in
the strategic development, management and analysis of programs that support
clinical development - from compound selection to Phase I-IV clinical studies.
ICON teams have successfully conducted over 1,900 development projects and
over 2,300 consultancy engagements across all major therapeutic areas. ICON
currently has over 4800 employees, operating from 50 locations in 30
countries. Further information is available at www.iconclinical.com.
For further information:
For further information: Lois Paul & Partners Susan Lombardo,
781-782-5767 email@example.com or Band and Brown David Vindel, +44207